Absci Corp (ABSI) concluded trading on Thursday at a closing price of $2.88, with 9.7 million shares of worth about $27.93 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 6.27% during that period and on July 17, 2025 the price saw a gain of about 5.11%. Currently the company’s common shares owned by public are about 127.54M shares, out of which, 111.47M shares are available for trading.
Stock saw a price change of 5.49% in past 5 days and over the past one month there was a price change of 2.13%. Year-to-date (YTD), ABSI shares are showing a performance of -27.09% which increased to 9.92% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.01 but also hit the highest price of $6.33 during that period. The average intraday trading volume for Absci Corp shares is 3.18 million. The stock is currently trading 6.43% above its 20-day simple moving average (SMA20), while that difference is up 4.02% for SMA50 and it goes to -12.73% lower than SMA200.
Absci Corp (NASDAQ: ABSI) currently have 127.54M outstanding shares and institutions hold larger chunk of about 65.99% of that.
The stock has a current market capitalization of $367.37M and its 3Y-monthly beta is at 2.03. It has posted earnings per share of -$0.93 in the same period. It has Quick Ratio of 5.72 while making debt-to-equity ratio of 0.04. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ABSI, volatility over the week remained 4.95% while standing at 6.11% over the month.
Stock’s fiscal year EPS is expected to rise by 7.58% while it is estimated to increase by 11.17% in next year. EPS is likely to grow at an annualized rate of 3.62% for next 5-years, compared to annual growth of -29.30% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on July 03, 2025 offering an Overweight rating for the stock and assigned a target price of $7 to it. Coverage by Needham stated Absci Corp (ABSI) stock as a Buy in their note to investors on January 22, 2025, suggesting a price target of $9 for the stock. On October 02, 2024, Guggenheim Initiated their recommendations, while on July 03, 2024, Morgan Stanley Initiated their ratings for the stock with a price target of $7. Stock get a Sector outperform rating from Scotiabank on March 14, 2024.
